New England Compounding Center recalls Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Fra
Recalled January 9, 2013 · FDA recall D-122-2013 · New England Compounding Center
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
8919 vials
Sold at
Nationwide
Description
Lack of Assurance of Sterility
Product
Omnipaque 240mg/mL PF, 300mg/mL PF, in 3 mL, 5 mL, and 10 mL, vials, manufactured by New England Compounding Center, Framingham, MA
Manufacturer(s)
New England Compounding Center
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →